Please ensure Javascript is enabled for purposes of website accessibility

3 Under-the-Radar Cannabis Stocks to Buy Right Now

By Keith Speights - Jun 21, 2021 at 5:55AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

They don't receive the attention that some pot stocks do, but these U.S. stocks could be huge winners.

Tilray, Sundial Growers, Canopy Growth. You've likely heard a lot about these stocks so far this year if you follow the cannabis industry at all. 

However, the best opportunities don't always lie with the most well-known stocks. Oftentimes, you can make a lot more money over the long run by finding stocks that aren't as widely followed. Here are three great under-the-radar cannabis stocks to buy right now.

Cannabis leaves on top of $100 bills.

Image source: Getty Images.

Ayr Wellness

Ayr Wellness (AYRW.F 0.00%) ranks as one of the fastest-growing U.S. cannabis multistate operators (MSOs). Once its acquisition of New Jersey's Garden State Dispensary closes, the company will have a presence in seven states.

In the first quarter of 2020, Ayr generated revenue of $58.4 million, up 74% year over year. It delivered adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of $18.4 million. CEO Jonathan Sandelman said that strong Q1 performance "represents the early innings" of Ayr's transformation.

That's a good assessment, in my view. Ayr has tremendous growth prospects in its current markets. The Garden State Dispensary deal should finalize in July. There's also the possibility that Florida could legalize recreational marijuana in the not-too-distant future. Ayr now has a major presence in Florida's medical cannabis market thanks to its acquisition of Liberty Health Sciences.

Compared to most of its peers, Ayr stock is practically dirt cheap. Its price-to-sales multiple currently stands below five. With the company's sales growth set to accelerate, I think Ayr is a stock that could realistically double in the second half of 2021.

Jushi Holdings

Jushi Holdings (JUSHF -1.48%) stands out as another up-and-coming U.S. MSO. It currently operates in seven states, with especially strong businesses in Pennsylvania and Illinois.

The company reported Q1 revenue of $32.3 million. This result reflected 275% year-over-year growth and an increase of nearly 30% from the previous quarter. Jushi posted positive adjusted EBITDA of $2.6 million. 

I fully expect that Jushi will keep up this momentum. The cannabis operator is expanding in several markets. The one that I'm particularly watching closely is Virginia. Jushi plans to have five medical cannabis dispensaries open in the state by the end of 2022. Virginia's recreational marijuana market is set to launch in 2024. 

Like Ayr, Jushi is a relative bargain compared to most marijuana stocks. Its shares currently trade at under 5.4 times trailing 12-month sales. Jushi's market cap remains below $1 billion, but I think this company will be worth a lot more than that within the next few years. 

Planet 13 Holdings

There simply isn't another company in the cannabis industry that's like Planet 13 Holdings (PLNH.F -6.25%). Planet 13 operates a cannabis SuperStore off the famous Las Vegas Strip that has become a tourist destination.

The company delivered revenue of $23.8 million in Q1, a year-over-year jump of nearly 42%. It posted adjusted EBITDA of $5.2 million. Those numbers are especially impressive considering that the COVID-19 pandemic continues to weigh on tourist traffic to Las Vegas. 

Planet 13 should enjoy accelerated growth as COVID worries fade. It hopes to build a cannabis consumption lounge within its Las Vegas SuperStore after key legislation passed in Nevada allowing such lounges. The company also launches its California cannabis SuperStore in July.

This stock isn't as cheap as Ayr and Jushi with a price-to-sales multiple of over 14. However, I think that Planet 13 has plenty of room to run. And if the door opens for the company to list its shares on a major U.S. stock exchange, Planet 13 won't remain an under-the-radar pot stock.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Ayr Wellness, Jushi Holdings, and Planet 13 Holdings Inc. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Planet 13 Holdings Inc. Stock Quote
Planet 13 Holdings Inc.
PLNH.F
$1.80 (-6.25%) $0.12
Canopy Growth Stock Quote
Canopy Growth
CGC
$2.87 (-12.50%) $0.41
Sundial Growers Inc. Stock Quote
Sundial Growers Inc.
SNDL
$2.69 (-4.27%) $0.12
Jushi Holdings Inc. Stock Quote
Jushi Holdings Inc.
JUSHF
$2.00 (-1.48%) $0.03
Ayr Wellness Inc. Stock Quote
Ayr Wellness Inc.
AYRW.F
$4.96 (0.00%) $0.00
Tilray Stock Quote
Tilray
TLRY
$3.84 (-10.70%) $0.46

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
379%
 
S&P 500 Returns
123%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/09/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.